Moderna says FDA refused its application for new mRNA flu vaccine

The U.S. Food and Drug Administration is refusing to consider Cambridge-based Moderna’s application for a new flu vaccine made with mRNA technology. Moderna has requested an urgent meeting with the FDA and noted it has applied for approval in Europe, Canada and Australia.